Dermata Therapeutics Inc. share price logo

Dermata Therapeutics Inc.

NASDAQ: DRMA

Small Cap

$1.35

+0.16

(+13.45%)

Live

as on

Dermata Therapeutics Inc. Stock Performance

as on June 18, 2026 at 5:25 am IST

  • Day's Low

    Day's High

    $1.20
    $1.37
    downward going graph

    11.11%

    Downside

    1.48%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.10
    $8.00
    downward going graph

    18.52%

    Downside

    492.59%

    Upside

    downward going graph

Dermata Therapeutics Inc. share price movements today

Previous Close
$1.19
Open
$1.21
Volume
484.0K
Day's Low - High
$1.20 - $1.37
52 Week Low - High
$1.10 - $8.00

Dermata Therapeutics Inc. Historical Returns

1 Month Return
0 %
3 Month Return
-2.46 %
1 Year Return
-83.18 %
3 Year Return
-99.57 %
5 Year Return
0 %

Dermata Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Dermata Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.8M

EPS (TTM)

-2.21

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-7.9M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-103.58%

Dermata Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Dermata Therapeutics Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$4.8MNANA0.00%NA
BUY$38.4B63.66%72.4912.55%NA
BUY$114.3B140.59%26.7335.51%NA
BUY$64.5B14.69%15.0229.65%0.58%

Stock Returns calculator for Dermata Therapeutics Inc. Stock including INR - Dollar returns

The Dermata Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Dermata Therapeutics Inc. investment value today

Current value as on today

₹20,875

Returns

-₹79,125

(-79.12%)

Returns from Dermata Therapeutics Inc. Stock

-₹80,932 (-80.93%)

Dollar Impact

₹1,808 (+1.81%)

Analyst Recommendation on Dermata Therapeutics Inc. Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Dermata Therapeutics Inc.. Average target price of $4

Dermata Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Dermata Therapeutics Inc..

What analysts predicted

66.25%UPSIDE

Target Price

$4

Current Price

$1.35

Analyzed by

7 Analysts

Target

$4.00

Dermata Therapeutics Inc. target price $4, a slight upside of 66.25% compared to current price of $1.35. According to 7 analysts rating.

Indian Investors' Interest in Dermata Therapeutics Inc. Stock

Search interest for Dermata Therapeutics Inc. Stock has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-56% versus previous 30 day period

Dermata Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-2
-3
-2
-3
-3
-2
-1
-1
-1
-1
EBITDA
-2
-3
-2
-3
-3
-2
-1
-1
-1
-1
Interest Expense
0
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-2
-3
-2
-3
-3
-2
-1
-1
-1
-1
Income Tax Expense
0
-3
-2
-
3
-
-
-
-
-
Net Income
-2
-3
-2
-3
-3
-2
-1
-1
-1
-1
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Dermata Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
Gross Profit
0
0
-
-
-
-
-
Operating Income
-4
-3
-7
-9
-8
-12
-7
EBITDA
-4
-3
-7
-9
0
-12
-7
Interest Expense
0
0
0
0
-
-
-
Depreciation
0
0
-
-
-
-
-
Income Before Tax
-4
-3
-7
-9
-7
-12
-7
Income Tax Expense
0
0
0
0
0
-
-
Net Income
-4
-3
-7
-9
-7
-12
-7
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Dermata Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-3
-2
-3
-3
-2
-1
-1
-1
-1
Operating Cash Flow
-2
-2
-3
-2
-1
-2
-1
-1
-2
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
-
2
4
0
8
0
0
4
1
Change in Cash
-2
0
1
-2
6
-3
-1
2
0

Dermata Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-3
-7
-9
-7
-12
-7,558
Operating Cash Flow
-4
-5
-8
-6
-11
-7,757
Investing Cash Flow
-
-
-
-
-
-
Financing Cash Flow
2
15
4
7
6
12,117
Change in Cash
-1
10
-4
1
-4
4,360

Global Institutional Holdings in Dermata Therapeutics Inc.

Funds
Holdings
Welch & Forbes LLC
0.5%
SBI Securities Co Ltd
0%
Citigroup Inc
0%
JPMorgan Chase & Co
0%
Barclays PLC
0%

Dermata Therapeutics Inc. News & Key Events

  • img

    Today's Timeline - 30 December

    Tue, 11:24 AM

    -

    Dermata Therapeutics closes $12.4 million private placement, shares rise 10.2% in after-hours trading.

Insights on Dermata Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Dermata Therapeutics, Inc. Common Stock has experienced a drawdown of -99.6%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 78.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 20.8% return, outperforming this stock by 104.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, DRMA stock has moved down by -48.3%

About Dermata Therapeutics Inc.

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
OrganisationDermata Therapeutics Inc.
Headquarters3525 Del Mar Heights Rd., San Diego, CA, United States, 92130
IndustryBiotechnology
CEOMr. Gerald T. Proehl
E-voting on sharesClick here to vote

Key Management of Dermata Therapeutics Inc.

Name

Title

Dr. Maria Bedoya Toro Munera M.B.A., Ph.D.

Senior Vice President of Regulatory Affairs & Quality Assurance

Mr. Gerald T. Proehl

Founder, President, CEO & Chairman

Mr. David F. Hale

Co-Founder & Lead Independent Director

Ms. Kyri K. Van Hoose CPA, M.B.A.

Senior VP & CFO

Dr. Christopher J. Nardo M.P.H., Ph.D.

Senior VP & Chief Development Officer

Mr. Sean Proehl

Associate General Counsel

Ms. Kyra Peckaitis

Vice President of Marketing

FAQs

What is Dermata Therapeutics Inc. share price today?

Dermata Therapeutics Inc. share price today is $1.35 as on . Dermata Therapeutics Inc. share today touched a day high of $1.37 and a low of $1.2.

What is the 52 week high and 52 week low for Dermata Therapeutics Inc. share?

Dermata Therapeutics Inc. share touched a 52 week high of $8 on and a 52 week low of $1.1 on . Dermata Therapeutics Inc. stock price today i.e. is trending at $1.35,which is 83.13% down from its 52 week high and 22.73% up from its 52 week low.

What is Dermata Therapeutics Inc.'s market capitalisation today?

Dermata Therapeutics Inc. market capitalisation is $0.00T as on .

How to invest in Dermata Therapeutics Inc. Stock (DRMA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Dermata Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dermata Therapeutics Inc. Shares that will get you 1.1111 shares as per Dermata Therapeutics Inc. share price of $1.35 per share as on June 17, 2026 at 11:55 pm IST.

What is the minimum amount required to buy Dermata Therapeutics Inc. Stock (DRMA) from India?

Indian investors can start investing in Dermata Therapeutics Inc. (DRMA) shares with as little as ₹94.5 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹945.00 in Dermata Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Dermata Therapeutics Inc. share’s latest price of $1.35 as on June 17, 2026 at 11:55 pm IST, you will get 7.4074 shares of Dermata Therapeutics Inc.. Learn more about fractional shares .